Sussman Norman 4
4 · DURECT CORP · Filed Jan 10, 2022
Insider Transaction Report
Form 4
DURECT CORPDRRX
Sussman Norman
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2022-01-06+398,380→ 398,380 totalExercise: $0.87Exp: 2032-01-06→ Common Stock (398,380 underlying)
Footnotes (1)
- [F1]The option will vest and become exercisable in installments of one-sixteenth (1/16) of the total number of shares at the end of each three month period following the grant date, subject to the Reporting Person providing continuous service to the Issuer through the applicable vesting date.